CD80
CD11c公司
CD86
CD40
免疫学
结肠炎
医学
免疫系统
树突状细胞
嗜铬粒蛋白A
T细胞
生物
细胞毒性T细胞
体外
免疫组织化学
表型
基因
生物化学
作者
Kunal Kapoor,Nour Eissa,Diane M. Tshikudi,Çharles N. Bernstein,Jean‐Eric Ghia
标识
DOI:10.3748/wjg.v27.i47.8138
摘要
BACKGROUND: cells. AIM: To investigate the association between CHR treatment and dendritic cells (DCs)-related markers in different immune compartments in colitis. METHODS: A model of acute UC-like colitis using dextran sulphate sodium (DSS) was used in addition to biopsies collected from UC patients. RESULTS: DCs stimulated with lipopolysaccharide. Pharmacological studies demonstrated an impact of CHR on the NF-κB pathway. In patients with active UC, CHR level was reduced and showed a negative linear relationship with CD11c and CD86. CONCLUSION: cells. CHR could be a potential therapy of UC.
科研通智能强力驱动
Strongly Powered by AbleSci AI